Amundi Asset Management US’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-35,022
Closed -$213K 1628
2020
Q3
$213K Hold
35,022
﹤0.01% 1384
2020
Q2
$311K Hold
35,022
﹤0.01% 1321
2020
Q1
$254K Buy
+35,022
New +$260K ﹤0.01% 1294

Other funds holding NPTN

Amundi Asset Management US's NPTN Position: Q4 2020 in Review

Amundi Asset Management US sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 35,022 shares — an estimated $213K sold.

Amundi Asset Management US first reported a position in NPTN in Q1 2020 and held it in 3 quarters. The position peaked at $311K in Q2 2020. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Amundi Asset Management US reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 35,022 NEOPHOTONICS CORP shares in Q4 2020, an estimated $213K.
  • Amundi Asset Management US first reported a position in NEOPHOTONICS CORP in Q1 2020 and held it in 3 quarters.
  • Amundi Asset Management US's NEOPHOTONICS CORP position peaked at $311K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.